7/23/2019 DAMC06

1/2

Antimycotics and antifungals for systemic use (ATC groups J02 &

D01BA)

Data source

Health care Data type Coverage* Data source(consumption)

Population(under surveillance)

Data source(population)

Community (primarycare sector)

Reimbursement 100% Health InsuranceCompany

8 450 565 Eurostat

* Proportion of total country population under surveillance.

ATC group J01 Community(primary care sector)

Hospital sector

Beta-lactam antibacterials, penicillins (J01C) 7.38 -

Other beta-lactam antibacterials (J01D) 1.95 -

Tetracyclines (J01A) 1.27 -

Macrolides, lincosamides and streptogramins (J01F) 3.59 -

Quinolone antibacterials (J01M) 1.47 -

Sulfonamides and trimethoprim (J01E) 0.23 -

Other J01 substances 0.37 -

Total 16.27 -

Antibacterials for systemic use (ATC group J01)

Consumption of antibacterials for systemic use (ATC group J01) in the community (primary care sector)and the hospital sector expressed in DDD per 1000 inhabitants and per day in 2013

This report has been generated from ESAC-Net data submitted to TESSy, The European Surveillance System on2015-10-19. The report reflects the state of submissions in TESSy as of 2015-10-19 at 17:31

1 / 2

Antimicrobial consumption in Austria,2013

7/23/2019 DAMC06

2/2

ATC groups J02 & D01BA Community(primary care sector)

Hospital sector

Terbinafine (D01BA02) 0.61 -

Amphotericin B (J02AA01)